A Multicenter Open-Label Study of RMC-6236 in Patients with Advanced Solid Tumors Harboring Specific Mutations in RAS

Go Back to All Clinical Trials

A Multicenter Open-Label Study of RMC-6236 in Patients with Advanced Solid Tumors Harboring Specific Mutations in RAS

Brief description of study

Clinical Study Identifier: s22-00364

ClinicalTrials.gov Identifier: NCT05379985

Principal Investigator: Salman Rafi Punekar.

Other Investigators: Maya Dimitrova, Samantha VanMaanen, Nancy Chan, Scot Niglio, Jessica Wang, Elaine Shum, Elise Roughan, Kristen Spencer, Sally Lau, Joshua K Sabari, Keriann M Scavone, Eneil De La Pena, Kirby Rodriguez, Vamsidhar Velcheti, Kathleen M Madden, Caitlin Elizabeth Ryan, Paul E. Oberstein, David R. Wise, Nina Beri, Janice Mehnert, Douglas K Marks.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Perlmutter Cancer Center

Clinical Trials & Research Studies